Fatal cholestatic hepatitis in an infant: An unusual etiologydownloads.hindawi.com/journals/cjgh/1995/649852.pdf · an etiology and institute specific sup-portive and/or therapeutic

Fatal cholestatic hepatitis in aninfant: An unusual etiology

MARK R OLIVER MBBS, ALFREDO PINTO MD, R BRENT SCOTT MDCM

OBSTRUCTIVE JAUNDICE REQUIRES

prompt investigation to identifyan etiology and institute specific sup-portive and/or therapeutic measures toprevent morbidity and mortality. Wereport a three-month-old infant girlwho presented with cholestatic jaun-dice and hepatitis that progressed tofulminant hepatic failure due to adeno-

virus type 5 infection. Postmortem di-agnosis of severe combinedimmunodeficiency syndrome (SCIDS)was made. Infection, viral or bacterial,can be a recognized but less commoncause of this clinical picture in infancy(1,2). However, neither adenovirus in-fection nor immunodeficiency hasbeen included as a cause of hepatitis or

cholestasis during infancy in compre-hensive summaries of the differentialdiagnosis (1-3).

CASE PRESENTATIONClinical history: A three-month-oldfemale born to unrelated Mennoniteparents was transferred from a regionalcentre (following a one-week admis-sion) to the Alberta Children’s Hospi-tal in Calgary, Alberta with cholestaticjaundice and hepatitis as indicated bytotal bilirubin of 68 �mol/L (normalless than 32) with a conjugated biliru-bin of 57 �mol/L and elevated liver en-zymes (aspartate aminotransferase 542U/L [normal 0 to 30] and alkaline phos-phate 1721 U/L [normal 75 to 400]). Atentative diagnosis of biliary atresia hadbeen made at the referring institutionon the basis of absent excretion of bileinto the small intestine during a nuclearmedical hepatobiliary scan. However,there were some unusual features thatweighed against the transfer diagnosisand suggested an infectious etiology.First, the child had also presented withfever, leukopenia (total white bloodcell count 3.2x109 cells/L, normal 5 to18.5) and microcytic, hypochromicanemia (hemoglobin 59 g/L, normal 95to 155). Second, the infant also had ahistory of failure to thrive, with a recentonset of otitis externa. Before transferthe infant commenced a course of bothbroad spectrum intravenous antibioticsand an oral antifungal agent. Cultures ofurine and blood obtained before treat-ment was initiated did not subsequently

BRIEF COMMUNICATION – HEPATOLOGY

MR OLIVER, A PINTO, RB SCOTT. Fatal cholestatic hepatitis in an infant: Anunusual etiology. Can J Gastroenterol 1995;9(4):217-220. An infant girl whopresented with cholestasis and hepatitis that rapidly progressed to fulminant liverfailure is reported. Postmortem examination yielded a diagnosis of demonstratedextensive hepatic necrosis due to adenovirus type 5 infection which had devel-oped in the setting of an occult primary immunodeficiency (severe combined im-munodeficiency). The aim of this report is to alert the physician to a rare cause ofcholestasis and hepatitis in infancy. Recognition of the combination of adenovi-ral infection with underlying primary immunodeficiency is a prerequisite tothe provision of genetic counselling.

Key Words: Adenovirus, Cholestasis, Hepatitis, Immunodeficiency

Hépatite choléstatique fatale chez un nourrisson : étiologieinhabituelle

RÉSUMÉ : Le cas d’un nourrisson de sexe féminin qui a présenté une choléstaseet une hépatite ayant progressé vers une insuffisance hépatique fulminante estrésumé ici. L’autopsie a permis de poser un diagnostic de nécrose hépatique éten-due attribuable à une infection à adénovirus de type 5 qui s’était développée dansle contexte d’une immunodéficience primitive occulte (immunodéficience com-binée grave). Le but de ce rapport est de sensibiliser les médecins à une cause rarede choléstase et d’hépatite chez les nourrissons. L’observation d’une infectionadénovirale combinée à une immunodéficience primitive sous-jacente est essen-tielle à tout counselling génétique.

Department of Pediatrics and Pathology, Alberta Children’s Hospital and University ofCalgary, Calgary, Alberta

Correspondence and reprints: Dr R Brent Scott, Department of Pediatrics, Health ScienceCentre, 3330 Hospital Drive NW, Calgary, Alberta T2N 4N1. Telephone 403-220-4556,Fax 403-283-3028, e-mail [email protected]

CAN J GASTROENTEROL VOL 9 NO 4 JUNE 1995 217

grow either bacterial or fungal patho-gens.

On admission to the Alberta Chil-dren’s Hospital, the following addi-tional information was obtained. Thepatient had been born at term (weight2.8 kg) and at home, in a Mennonite

colony in Mexico. She had been exclu-sively bottle-fed with Enfalac (MeadJohnson Canada) since birth and apartfrom poor weight gain, which the par-ents attributed to ‘difficult feeding’, shehad been relatively well until twoweeks before admission to the referring

hospital, at which time she was jaun-diced and passing both acholic stoolsand dark urine. These symptoms wereaccompanied by a discharging right earand pallor. She had never been immu-nized or been given any prescribed ornonprescribed medications. The pati-ent’s 19-month-old sibling was well.Several unexplained deaths in the firstyears of life were reported on the mater-nal side of the family.

Physical examination confirmedfailure to thrive; both the patient’sheight and weight were below the fifthpercentile. She was afebrile, and ap-peared pale, jaundiced and poorlynourished. There was a yellow dis-charge from her right ear due to otitisexterna and mild oral candidiasis. Bothtonsillar and lymphoid tissue wereclinically present. She was noticeablyirritable on stimulation; however,there was no evidence of focal neuro-logical signs. Her liver was 7 cm in spanand her spleen was palpable 2 cm belowthe left costal margin. There was noother clinical evidence of chronic liverdisease.

Laboratory investigations per-formed on admission are summarized inTable 1. Within 12 h of admission thepatient suffered a significant deteriora-tion characterized by the clinical find-ings of shock, bleeding diathesis anddeteriorating liver function. She re-ceived supportive care including vol-ume expansion with fresh frozenplasma, antibiotics, pooled immuno-globulin and vitamin K. Serologicalinvestigations for hepatitis A, B and C,cytomegalovirus, toxoplasmosis, herpessimplex and human immunodeficiencyvirus-1 were negative. Plasma aminoacids and urinary organic acid profilefailed to detect an underlying meta-bolic disorder. Repeat blood and urinecultures were negative for bacterial orfungal organisms. Rotavirus was iso-lated from the stools and adenoviruscultured from the patient’s nasopha-rynx eight days following admission tothe Children’s Hospital. Despite allsupportive efforts the patient’s coagu-lopathy persisted (uncorrected byblood products and vitamin K) andher liver function continued to deterio-rate (Table 1). In addition, she devel-

TABLE 1Laboratory investigations

On admission Before death Normal values

Hemoglobin (g/L) 94 75 110-147

White blood cells (x109/L) 3 4.9 6-18

Lymphocytes (x109/L) 0.5 1.8 2.8-14.4

Platelets (x109/L) 167 75 150-550

Prothrombin time (s) 15.1 28 11.9-17.7

Activated partial thromboplastin time

(s)

33 >150 23.7-37.9

Fibrinogen (g/L) 2.0 1.4 2-4

D-dimers (fibrinogen equivalent units) <0.05 <0.05 <0.5

Total bilirubin (�mol/L) 55 108 5-23

Conjugated bilirubin (�mol/L) 25 76 0-10

Gamma glutamyltransferase (U/L) 1518 652 16-43

Aspartate aminotransferase (U/L) 1656 23,250 12-50

Alanine transaminase (U/L) 480 1740 5-40

Albumin (g/L) 24 22 35-50

Immunoglobulin G (U/L) 0.73 – 3.45-12.36

Immunoglobulin A (U/L) <0.07 – 0. 14-1.23

Immunoglobulin M (U/L) 0.17 – 0.43-1.73

Alpha-1 antitrypsin (U/L) – 3.48 0.85-2.65

Urinary reducing substances Negative

Figure 1) Light microscopy demonstrates extensive necrosis of the hepatocytes without a significantinflammatory response. Some hepatocytes contain intranuclear inclusions consistent with viral infec-tion (hematoxylin and eosin x262)

218 CAN J GASTROENTEROL VOL 9 NO 4 JUNE 1995

OLIVER et al

oped significant neurological dysfunc-tion characterized by irritability,opisthotonos, apnea and seizures in theabsence of evidence of an intracranialbleed on cerebral computed tomo-graphic scan (or later at autopsy). Shedied eight days following admission.Autopsy findings: Autopsy revealed adiffuse granular liver, which on his-tological assessment showed exten-sive areas of necrosis with minimal in-flammation and normal portal tracts.Hepatocytes at the periphery of ne-crotic areas contained round nucleiwith acidophilic inclusions sugges-tive of viral infection (Figure 1). Elec-tron microscopic examination of livertissue revealed the presence of adenovi-rus particles (Figure 2). The adenoviruswas serotyped as type 5 by standard neu-tralization tests using adenovirus type 5reference antisera (4). At the time ofautopsy, adenovirus was cultured fromstools, heart, lungs, liver, cerebrospinalfluid and throat, reflecting terminalviremia. There was no evidence of in-flammation or viral inclusion bodiesdetected in other organs apart from theliver. Examination of the reticuloendo-thelial system disclosed a small thymuswith complete depletion of lympho-cytes, dysplastic epithelium and ab-sence of Hassall’s corpuscles. Thelymph nodes, spleen and Peyer’spatches were depleted in lymphocytesand showed no evidence of germinalcentres. These histological findings arecharacteristic of severe combined im-munodeficiency (5).

DISCUSSIONA diagnosis of SCIDS, a heteroge-

nous group of disorders characterizedby a gross functional impairment ofboth T and B lymphocytes, was madein our patient. This diagnosis is sup-ported by both laboratory and autopsyfindings including the presence of lym-phocytopenia, hypogammaglobuline-mia, thymic dysplasia and generalizedlymphoid hypoplasia. There is usually apositive family history obtained in 50%of patients with SCIDS which may re-flect an autosomal recessive, dominantor X-linked pattern of inheritance (6).It is possible that in this patient’s Men-nonite background there is an unrecog-

nized basis for recessive inheritance;however, the precise inheritance of herdisease remains to be elucidated.

Adenovirus can, like many other vi-ruses, take advantage of an abnormalimmune system and produce either per-sistent or generalized infections(4,7-11). In the immunocompromisedpatient with adenoviral infection thereis a case fatality rate of over 50% inthose who present with hepatitiscompared with less than 10% in theimmunocompetent patient (9). Whenadenoviral infection occurs as a resultof a primary immunodeficiency, over90% of cases are associated with SCIDS

(9). Of the 19 reported adenoviral in-duced fatalities in patients with SCIDS,there has been only one previously re-ported case with adenovirus type 5 in-fection, and in that patient the clinicalpicture and outcome was similar to thatdescribed for our patient (10).

There is no specific treatment forSCIDS although a variety of natural andsynthetic products have been used withminimal success, including thymic hu-moral factor, pooled immunoglobulinG (which was used unsuccessfully inour patient) and interferon (9). Morerecently ganciclovir has shown somepromise in disseminated adenoviral in-fection after liver transplantation (12).

Lastly, successful treatment of fulmi-nant viral hepatitis (ECHO virus type11) by orothotopic liver transplanta-tion has been reported in an infant(13). Despite post-transplant immu-nosuppressive drug therapy, this latterpatient’s ECHO viral hepatitis did notrecur. Such aggressive treatment war-rants further assessment in the case ofcertain viral-induced hepatic infec-tions. However, because of our pati-ent’s underlying severe immunodefi-ciency syndrome we do not believe thatliver transplantation would have beenan appropriate therapeutic option.

CONCLUSIONSThe aim of this report was to alert

the physician to a rare cause of cho-lestasis and hepatitis in infancy. Whileadenoviral hepatitis and cholestasis ininfants with SCIDS is rare, and usuallylethal even with early recognition andtreatment, it should not go unrecog-nized because of the need to providegenetic counselling to the family.

ACKNOWLEDGEMENTS: The authorsthank Roberta Funk for typing the manu-script. Mark Oliver is a recipient of an Al-berta Children’s Hospital FoundationFellowship.

Figure 2) Hepatocyte showing the typical crystalline array of adenovirus particles withinthe nucleus (uranyl acetate-lead citrate x5216)

CAN J GASTROENTEROL VOL 9 NO 4 JUNE 1995 217

Fatal cholestatic hepatitis

REFERENCES1. Balistreri WF. Neonatal cholestasis:

lessons from the past, issues for thefuture. Semin Liver Dis 1987;7:61-6.

2. Felber S, Sinatra F. Systemic disordersassociated with neonatal cholestasis.Semin Liver Dis 1987;7:108-18.

3. Moyers MS, Balistreri WF. Prolongedneonatal obstructive jaundice. In:Walker WA, Durie PR, Hamilton JR,Walker-Smith JA, Watkin JB, eds.Pediatric Gastrointestinal Disease.Pathophysiology, Diagnosis andManagement, vol 2. Toronto:BC Decker, 1991:835-48.

4. Washington K, Gossage DL, GottfriedMR. Pathology of the liver in severecombined immunodeficiency and DiGeorge syndrome. Pediatr Pathol1993;13:485-504.

5. Linder J, Purtillo DT. Current concepts

of immunodeficiency disorders. ModPathol 1990;3:524-44.

6. Waldmann TA. Immunodeficiencydiseases: primary and acquired. In:Samter M, Talmage DW, Frank MM,Austen KF, Claman HN, eds. Immuno-logical Diseases, 4th edn. Toronto:Little, Brown & Co, 1988:411-67.

7. Ohbu M, Sasaki K, Okudaira M, IidakaK, Aoyama Y. Adenovirus hepatitis ina patient with severe combinedimmunodeficiency. Acta Pathol Jpn1987;37:655-64.

8. Wigger HJ, Blanc WA. Fatal hepaticand bronchial necrosis and adenovirusinfection with thymic alymphoplasia.N Engl J Med 1966;275:870-4.

9. Heirholzer JC. Adenovirus in theimmunocompromised host. ClinMicrobiol Rev 1992;5:262-74.

10. South MA, Dolen J, Beach DK, Mirkovic

RR. Fatal adenovirus hepatic necrosisin severe combined immunodeficiency.Pediatr Infect Dis J 1982;1:416-9.

11. Spencer MJ, Cherry JD. Adenoviralinfections. In: Feigin KD, Cherry JD,eds. Pediatric Infectious Disease, 3rdedn. Philadelphia: WB Saunders Co,1992:1670-87.

12. Wreghitt TG, Gray JJ, Ward KN, et al.Disseminated adenoviral infection afterliver transplantation and its possibletreatment with ganciclovir.J Infect 1989;19:88-9.

13. Chuang E, Maller ES, Hoffman MA,Hodinka RL, Altschuler SM.Successful treatment and fulminantEchovirus 11 infection in a neonatal byorthotopic liver transplantation.J Pediatr Gastroenterol Nutr1993;17:211-4.

220 CAN J GASTROENTEROL VOL 9 NO 4 JUNE 1995

OLIVER et al

Submit your manuscripts athttp://www.hindawi.com

Stem CellsInternational

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014


MEDIATORSINFLAMMATION

of


Behavioural Neurology

EndocrinologyInternational Journal of



Disease Markers


BioMed Research International

OncologyJournal of



Oxidative Medicine and Cellular Longevity


PPAR Research

The Scientific World JournalHindawi Publishing Corporation http://www.hindawi.com Volume 2014

Immunology ResearchHindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Journal of

ObesityJournal of



Computational and Mathematical Methods in Medicine

OphthalmologyJournal of


Diabetes ResearchJournal of



Research and TreatmentAIDS


Gastroenterology Research and Practice


Parkinson’s Disease

Evidence-Based Complementary and Alternative Medicine

Volume 2014Hindawi Publishing Corporationhttp://www.hindawi.com

Documents

Fatal cholestatic hepatitis in an infant: An unusual etiologydownloads.hindawi.com/journals/cjgh/1995/649852.pdf · an etiology and institute specific sup-portive and/or therapeutic